Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors.
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors. J Ovarian Res. 2021 Apr 22; 14(1):55.
View in:
PubMed
subject areas
Animals
Carcinoma, Endometrioid
Cisplatin
Female
Humans
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Mice
Ovarian Neoplasms
Survival Analysis
authors with profiles
Caner Saygin